stage IVA colon cancer
Showing 1 - 25 of >10,000
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma
Terminated
- Metastatic Colon Adenocarcinoma
- +27 more
- Binimetinib
- +3 more
-
San Francisco, California
- +1 more
Jan 5, 2023
Metastatic Colon Carcinoma, Stage IV Colon Cancer AJCC v8, Stage IVA Colon Cancer AJCC v8 Trial in New Brunswick (NBT-NM108)
Not yet recruiting
- Metastatic Colon Carcinoma
- +4 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Apr 13, 2022
Advanced Colon Adenocarcinoma, Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma Trial in Duarte
Active, not recruiting
- Advanced Colon Adenocarcinoma
- +24 more
- Ipilimumab
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 22, 2022
Metastatic Colon Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Carcinoma Trial in United States (Laboratory
Active, not recruiting
- Metastatic Colon Carcinoma
- +24 more
- Laboratory Biomarker Analysis
- +2 more
-
Corona, California
- +7 more
Oct 26, 2022
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Adenocarcinoma Trial in Houston (CXCR1/2
Recruiting
- Metastatic Colon Adenocarcinoma
- +20 more
- CXCR1/2 Inhibitor SX-682
- Nivolumab
-
Houston, TexasM D Anderson Cancer Center
Aug 17, 2022
Metastatic Colorectal Carcinoma, Recurrent Colon Carcinoma, Refractory Colorectal Carcinoma Trial in Livingston, New Brunswick
Recruiting
- Metastatic Colorectal Carcinoma
- +5 more
- Oxaliplatin
- Trifluridine and Tipiracil Hydrochloride
-
Elizabeth, New Jersey
- +5 more
Oct 17, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Glioma Trial in Los Angeles (Computed
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +19 more
- Computed Tomography
- +3 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Aug 19, 2022
Comprehensive Gene Sequencing in Guiding Treatment
Completed
- Recurrent Breast Cancer
- +7 more
- cytology specimen collection procedure
- laboratory biomarker analysis
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Oct 21, 2021
Colon Adenocarcinoma, High-Frequency Microsatellite Instability, Metastatic Malignant Solid Tumor Trial in Houston
Active, not recruiting
- Colon Adenocarcinoma
- +10 more
- Anti-PD-L1/TGFbetaRII Fusion Protein M7824
-
Houston, TexasM D Anderson Cancer Center
Jan 12, 2022
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Adenocarcinoma Trial in Houston
Recruiting
- Metastatic Colon Adenocarcinoma
- +30 more
- Abemaciclib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 24, 2022
Metastatic or Unresectable Colon or Rectal Cancer forCOLOMATE
Recruiting
- Metastatic Colon Adenocarcinoma
- +19 more
- Genetic Testing
-
Scottsdale, Arizona
- +17 more
Mar 2, 2022
Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker
Active, not recruiting
- Acute Myeloid Leukemia
- +66 more
- Best Practice
- +3 more
-
Fullerton, CaliforniaVirginia K Crosson Cancer Center
Jan 31, 2022
Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IIA Colon Cancer Trial in Cleveland (positron emission tomography,
Completed
- Recurrent Colon Cancer
- +17 more
- positron emission tomography
- +3 more
-
Cleveland, OhioUniversity Hospitals Seidman Cancer Center, Case Comprehensive C
Apr 26, 2021
Advanced Colorectal Carcinoma, Metastatic Colon Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in United States
Recruiting
- Advanced Colorectal Carcinoma
- +26 more
- Irinotecan
- +2 more
-
Tampa, Florida
- +3 more
Jun 22, 2022
Clinical Stage IV Esophageal Adenocarcinoma AJCC v8, Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8, Clinical
Recruiting
- Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
- +44 more
- Best Practice
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 3, 2021
Colon Carcinoma Metastatic in the Liver, Colorectal Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Atlanta, Rochester
Active, not recruiting
- Colon Carcinoma Metastatic in the Liver
- +13 more
- Anti-SEMA4D Monoclonal Antibody VX15/2503
- +3 more
-
Atlanta, Georgia
- +3 more
Dec 15, 2021
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Colorectal Carcinoma Trial in Rochester
Recruiting
- Metastatic Colon Adenocarcinoma
- +10 more
- Colorectal Cancer Peptide Vaccine PolyPEPI1018
- Trifluridine and Tipiracil Hydrochloride
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 10, 2022
Spatial Transcriptomics of Stage IVa Nasopharyngeal Carcinoma
Not yet recruiting
- Stage IVA Nasopharyngeal Carcinoma
- Intensity modulated radiation therapy (IMRT) combined with chemotherapy
-
Nanjing, ChinaJiangsu Cancer Hospital
Jun 21, 2023
Clinical Significance of Marginal Acute Inflammation for Stage
Completed
- Inflammation
- Colon Cancer
- MAI detection
- (no location specified)
Nov 11, 2023
Nasopharyngeal Carcinoma Trial in Fuzhou (without concurrent cisplatin chemo, with concurrent cisplatin chemo)
Not yet recruiting
- Nasopharyngeal Carcinoma
- without concurrent cisplatin chemotherapy
- with concurrent cisplatin chemotherapy
-
Fuzhou, Fujian, ChinaDepartment of radiation oncology, Fujian cancer hospital
Oct 18, 2023
ArTificial inTelligence-based RAdiogenomics in Colon Tumors
Recruiting
- Colon Cancer Stage II
- Colon Cancer Stage III
-
Roma, RM, ItalyAOU Sant'Andrea
Oct 24, 2023
Colorectal Cancer Trial in Taipei (Colectomy with NOSE procedure)
Recruiting
- Colorectal Cancer
- Colectomy with NOSE procedure
-
Taipei, TaiwanNational Taiwan University Hospital
Jul 23, 2023
Colon Adenocarcinoma, Microsatellite Stable Colon Carcinoma, Stage IIB Colon Cancer AJCC v8 Trial (drug, biological, procedure,
Not yet recruiting
- Colon Adenocarcinoma
- +4 more
- Encorafenib
- +5 more
- (no location specified)
Jan 24, 2023
Colonic Tumors Trial (Dostarlimab, CAPEOX, FOLFOX)
Not yet recruiting
- Colonic Neoplasms
- Dostarlimab
- +2 more
- (no location specified)
May 3, 2023